Company / Operating Income per Share
BioRestorative Therapies, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.26
FY2025
5-year range
-$36.77 / -$2.26
FY2021-FY2025
Trend
+30.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 4 consecutive years, from $-36.77 in FY2021 to $-2.26 in FY2025.
Based on SEC 10-K filings.
-2.26 in FY2025.
Improved from $-4.14 to $-2.26 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s operating income per share has grown for 4 consecutive years.
- In FY2025, operating income per share increased 30.1% year-over-year.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.26 | +30.1% |
| FY2024 | -$3.23 | +21.9% |
| FY2023 | -$4.14 | +23.2% |
| FY2022 | -$5.39 | +85.3% |
| FY2021 | -$36.77 | -33845.8% |
| FY2020 | -$0.11 | +83.4% |
| FY2019 | -$0.65 | +52.4% |
| FY2018 | -$1.37 | +17.3% |
| FY2017 | -$1.66 | +23.5% |
| FY2016 | -$2.17 | +25.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026